Home      |      About us      |      Administration      |      Research      |      Scientist      |      Research Progress      |      Int’l cooperation      |      News      |      Join us
Location: home» News» New Papers
Tumor suppressor p53 inhibits porcine epidemic diarrhea virus infection via interferon-mediated antiviral immunity. Mol Immunol. 2019 Feb 18;108:68-74

Hao Z , Fu F , Cao L , Guo L , Liu J , Xue M , Feng L .

Mol Immunol. 2019 Feb 18;108:68-74. doi: 10.1016/j.molimm.2019.02.005. [Epub ahead of print]



p53 is a tumor suppressor gene that can be activated in many contexts, such as DNA damage or stressful conditions. p53 has also been shown to be important for responses to certain viral infections. Porcine epidemic diarrhea virus (PEDV) is a major enteric pathogen of the coronavirus family that causes extensive mortality among piglets. The involvement of p53 during PEDV infection has not previously been investigated. In this study, we detected p53 upregulation in response to PEDV infection. Treatment with a p53 specific activator or p53 overexpression markedly decreased viral replication, and we showed that there was more viral progeny produced in p53 knock-out cells than in p53 wild-type cells. Finally, we demonstrated that inhibition of viral infection by p53 was mediated via p53-dependent IFN signaling, leading to IFN-stimulated response element (ISRE) activation, as well as the upregulation of IFN-stimulated genes (ISGs) and IFN-β released from infected cells. These findings demonstrate that p53 suppresses PEDV infection, offering a novel therapeutic strategy for combatting this deadly disease in piglets.

Copyright © 2019. Published by Elsevier Ltd.


Interferon pathway; Porcine epidemic diarrhea virus; Tumor suppressor p53; Viral infection

Previous: Infection Studies in Pigs and Porcine Airway Epithelial Cells Reveal an Evolution of A(H1N1)pdm09 Influenza A Viruses Toward Lower Virulence. J Infect Dis. 2019 Feb 18
Next: [Microfold cells-targeting antigen delivery: a promising strategy to enhance the efficacy of mucosal vaccines]. Sheng Wu Gong Cheng Xue Bao. 2019 Feb 25;35(2):216-225
COPYRIGHT (C) 2015 HVRI.AC.CN ALL RIGHTS RESERVED 技术支持:中国农业科学院农业信息研究所 ICP:05001785